Close

Sm Antigen

Smith antigen (Sm Ag) is one of four autoantigens commonly referred to as extractable nuclear antigens (ENA). The other ENAs are SS-A/Ro, SS-B/La, and RNP. Each ENA is composed of one or more proteins associated with small nuclear or cytoplasmic RNA species (snRNP) ranging in size from 80 to 350 nucleotides. Antibodies to ENA are common in patients with connective tissue diseases, including lupus erythematosus (LE), mixed connective tissue disease, Sjogren syndrome, scleroderma, and polymyositis/dermatomyositis. Anti-Sm is found almost exclusively in people with lupus and occurs in about 20% of cases, although the incidence varies among different ethnic groups. It is rarely found in people with other rheumatic diseases, and its incidence in healthy individuals is less than 1%. The anti-Sm antibody is usually measured by one of four methods: ELISA, immunodiffusion, or hemagglutination.

Have questions about a product?

Contact us to learn more about Meridian’s molecular or immunoassay reagent portfolio. We want to hear from you!

Contact A Specialist
Filter By:
Clear Results
3 Results
Name
Type
Format
Host/Source
Isotype
Tested Apps
Unit
Catalog
SDS
COA
Request Sample
anti Sm antigen
Monoclonal
Purified
Human Donor
N/A
EIA,ID
ML
K07108H
Sm antigen
Antigen
Aff.Pur.
Bovine Thymus
N/A
EIA
MG
A3C303B
Sm (Smith) antigen
Antigen
Aff.Pur.
Bovine Thymus
N/A
EIA
UT
A07303B

Get In Touch With A Specialist

Have questions about a product? Want to learn more about Meridian’s molecular or immunoassay reagent portfolio? We want to hear from you!


By submitting your information in this form, you agree that your personal information may be stored and processed in any country where we have facilities or service providers, and by using our “Contact Us” page you agree to the transfer of information to countries outside of your country of residence, including to the United States, which may provide for different data protection rules than in your country. The information you submit will be governed by our Privacy Statement.

Learn More About Us

About

Welcome to

Please select your country to continue

Continue
CN